Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3

Blood

Volumn 122, Issue 5, 2013, Pages 807-816

  Burnier, Laurent ^a   Mosnier, Laurent O ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALKALINE PHOSPHATASE; ENDOTHELIAL PROTEIN C RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 3; THROMBIN; VASCULOTROPIN; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; MUTANT PROTEIN; PROCR PROTEIN, HUMAN; PROTEASE-ACTIVATED RECEPTOR 3; PROTEIN C; THROMBIN RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME MECHANISM; MALE; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; CAPILLARY PERMEABILITY; CELL STRAIN HEK293; ENZYME ACTIVE SITE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; CAPILLARY PERMEABILITY; CATALYTIC DOMAIN; ENDOTHELIUM, VASCULAR; HEK293 CELLS; HUMANS; MUTANT PROTEINS; PROTEIN C; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; THROMBIN; TRANSFECTION;

EID: 84886430553     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-488957     Document Type: Article

References (44)

1. Esmon CT. The protein C pathway. Chest. 2003; 124(3 Suppl):26S-32S.
2. Dahlbäck B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett. 2005;579(15): 3310-3316.
3. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007; 109(8):3161-3172.
4. Rezaie AR. The occupancy of endothelial protein C receptor by its ligand modulates the par-1 dependent signaling specificity of coagulation proteases. IUBMB Life. 2011;63(6):390-396.
5. Esmon CT. The endothelial protein C receptor. Curr Opin Hematol. 2006;13(5):382-385.
6. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64(6):1057-1068.
7. Mosnier LO, Griffin JH. Inhibition of staurosporineinduced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J. 2003;373(Pt 1):65-70.
8. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296(5574):1880-1882.
9. Mosnier LO, Gale AJ, Yegneswaran S, Griffin JH. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. Blood. 2004;104(6):1740-1744.
10. Bae JS, Yang L, Manithody C, Rezaie AR. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J Biol Chem. 2007;282(12): 9251-9259.
11. Mosnier LO, Yang XV, Griffin JH. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions. J Biol Chem. 2007;282(45):33022-33033.
12. Mosnier LO, Zampolli A, Kerschen EJ, et al. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood. 2009;113(23):5970-5978.
13. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204(10):2439-2448.
14. Xu J, Ji Y, Zhang X, Drake M, Esmon CT. Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccarideinduced septic shock. J Thromb Haemost. 2009; 7(5):851-856.
15. Russo A, Soh UJ, Paing MM, Arora P, Trejo J. Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc Natl Acad Sci USA. 2009;106(15):6393-6397.
16. Bae JS, Yang L, Rezaie AR. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci USA. 2007; 104(8):2867-2872.
17. Soh UJ, Trejo J. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through b-arrestin and dishevelled-2 scaffolds. Proc Natl Acad Sci USA. 2011;108(50): E1372-E1380.
18. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000; 407(6801):258-264.
19. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature. 2000;404(6778):609-613.
20. Hansen KK, Saifeddine M, Hollenberg MD. Tethered ligand-derived peptides of proteinaseactivated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells. Immunology. 2004;112(2): 183-190.
21. Ishihara H, Connolly AJ, Zeng D, et al. Proteaseactivated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386(6624):502-506.
22. Kaufmann R, Schulze B, Krause G, Mayr LM, Settmacher U, Henklein P. Proteinase-activated receptors (PARs): the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. Regul Pept. 2005;125(1-3):61-66.
23. Guo H, Liu D, Gelbard H, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;41(4): 563-572.
24. Madhusudhan T, Wang H, Straub BK, et al. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood. 2012;119(3):874-883.
25. Sanna MG, Wang SK, Gonzalez-Cabrera PJ, et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol. 2006;2(8): 434-441.
26. Miles AA, Miles EM. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol. 1952;118(2): 228-257.
27. Liaw PCY, Mather T, Oganesyan N, Ferrell GL, Esmon CT. Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor. J Biol Chem. 2001;276(11):8364-8370.
28. Deans TL, Cantor CR, Collins JJ. A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell. 2007;130(2):363-372.
29. Sen P, Sahoo S, Pendurthi UR, Rao LV. Zinc modulates the interaction of protein C and activated protein C with endothelial cell protein C receptor. J Biol Chem. 2010;285(26): 20410-20420.
30. Mosnier LO, Sinha RK, Burnier L, Bouwens EA, Griffin JH. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood. 2012; 120(26):5237-5246.
31. Cumashi A, Ansuini H, Celli N, et al. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Thromb Haemost. 2001;85(3): 533-538.
32. McLaughlin JN, Patterson MM, Malik AB. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA. 2007;104(13):5662-5667.
33. Scarborough RM, Naughton MA, Teng W, et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem. 1992;267(19): 13146-13149.
34. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318-1321.
35. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost. 2010;103(1): 40-55.
36. Bae JS, Yang L, Rezaie AR. Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells. J Thromb Haemost. 2008;6(6):954-961.
37. Berg DT, Gerlitz B, Shang J, et al. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci USA. 2003;100(8):4423-4428.
38. Cao C, Gao Y, Li Y, Antalis TM, Castellino FJ, Zhang L. The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest. 2010;120(6):1971-1980.
39. Yang XV, Banerjee Y, Fernández JA, et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells. Proc Natl Acad Sci USA. 2009; 106(1):274-279.
40. White TC, Berny MA, Tucker EI, et al. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J Thromb Haemost. 2008;6(6):995-1002.
41. Menschikowski M, Hagelgans A, Eisenhofer G, Siegert G. Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Exp Cell Res. 2009;315(15): 2673-2682.
42. Sesin CA, Yin X, Esmon CT, Buyon JP, Clancy RM. Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: in vivo and in vitro evidence. Kidney Int. 2005;68(1):110-120.
43. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seventransmembrane receptors. Nat Rev Drug Discov. 2010;9(5):373-386.
44. Bae JS, Rezaie AR. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost. 2008;100(1): 101-109.